Home Research COVID-19 Services Publications People Teaching Job Opening News Forum Lab Only
Online Services

I-TASSER I-TASSER-MTD C-I-TASSER CR-I-TASSER QUARK C-QUARK LOMETS MUSTER CEthreader SEGMER DeepFold DeepFoldRNA FoldDesign COFACTOR COACH MetaGO TripletGO IonCom FG-MD ModRefiner REMO DEMO DEMO-EM DMFold SPRING COTH Threpp PEPPI BSpred ANGLOR EDock BSP-SLIM SAXSTER FUpred ThreaDom ThreaDomEx EvoDesign BindProf BindProfX SSIPe GPCR-I-TASSER MAGELLAN ResQ STRUM DAMpred

TM-score TM-align US-align MM-align RNA-align NW-align LS-align EDTSurf MVP MVP-Fit SPICKER HAAD PSSpred 3DRobot MR-REX I-TASSER-MR SVMSEQ NeBcon ResPRE TripletRes DeepPotential WDL-RF ATPbind DockRMSD DeepMSA FASPR EM-Refiner GPU-I-TASSER

BioLiP E. coli GLASS GPCR-HGmod GPCR-RD GPCR-EXP Tara-3D TM-fold DECOYS POTENTIAL RW/RWplus EvoEF HPSF THE-DB ADDRESS Alpaca-Antibody CASP7 CASP8 CASP9 CASP10 CASP11 CASP12 CASP13 CASP14

You can:

GPCR

NameAdenosine receptor A2a
SpeciesHomo sapiens (Human)
GeneADORA2A
SynonymRDC8
adenosine receptor A2a
A2A receptor
A2-AR
DiseaseRadionuclide imaging
Diabetic foot ulcer
Glaucoma
Hypertension
Neuropathic pain
[ Show all ]
Length412
Amino acid sequenceMPIMGSSVYITVELAIAVLAILGNVLVCWAVWLNSNLQNVTNYFVVSLAAADIAVGVLAIPFAITISTGFCAACHGCLFIACFVLVLTQSSIFSLLAIAIDRYIAIRIPLRYNGLVTGTRAKGIIAICWVLSFAIGLTPMLGWNNCGQPKEGKNHSQGCGEGQVACLFEDVVPMNYMVYFNFFACVLVPLLLMLGVYLRIFLAARRQLKQMESQPLPGERARSTLQKEVHAAKSLAIIVGLFALCWLPLHIINCFTFFCPDCSHAPLWLMYLAIVLSHTNSVVNPFIYAYRIREFRQTFRKIIRSHVLRQQEPFKAAGTSARVLAAHGSDGEQVSLRLNGHPPGVWANGSAPHPERRPNGYALGLVSGGSAQESQGNTGLPDVELLSHELKGVCPEPPGLDDPLAQDGAGVS
UniProtP29274
Protein Data Bank4ug2, 4eiy, 3vga, 3vg9, 3uzc, 3uza, 3rfm, 3rey, 3pwh, 5iu4, 3eml, 2ydv, 2ydo, 3qak, 4uhr, 5g53, 5olh, 5olo, 5olv, 5olz, 5om1, 5om4, 5uvi, 5vra, 5wf5, 5wf6, 6aqf, 6gdg, 5olg, 5nm4, 5iu7, 5iu8, 5iua, 5iub, 5jtb, 5k2a, 5k2b, 5mzj, 5mzp, 5n2r, 5nlx, 5nm2
GPCR-HGmod modelP29274
3D structure modelThis structure is from PDB ID 4ug2.
BioLiPBL0213760, BL0350712, BL0350713,BL0350714,BL0350715, BL0353317,BL0353318, BL0357562, BL0357563,BL0357564,BL0357565, BL0357566, BL0357567,BL0357568,BL0357569, BL0379362,BL0379363,BL0379364, BL0379725, BL0379726,BL0379727,BL0379728, BL0379729, BL0385550, BL0350708,BL0350709,BL0350710,, BL0350707, BL0350703,BL0350704,BL0350705,, BL0215974, BL0215975, BL0227995, BL0227996, BL0227997,BL0227998,BL0227999, BL0312021,BL0312022, BL0312023, BL0350692, BL0350693,BL0350694,BL0350695,, BL0350697, BL0350698,BL0350699,BL0350700,, BL0350702, BL0385551,BL0385552,BL0385553, BL0385557, BL0385558,BL0385559,BL0385560,, BL0401931,BL0401932,BL0401933, BL0401934, BL0401935,BL0401936,BL0401937, BL0401938, BL0401939,BL0401940,BL0401941,, BL0401943, BL0401944,BL0401945,BL0401946,, BL0401948, BL0401949,BL0401950,BL0401951,, BL0401954,BL0401955,BL0401956,, BL0405662, BL0405663, BL0401930, BL0401927,BL0401928,BL0401929, BL0401926, BL0385572, BL0385573,BL0385574,BL0385575, BL0393144, BL0393145, BL0393146, BL0393147,BL0393148,BL0393149, BL0393150, BL0393151,BL0393152, BL0398902, BL0398903,BL0398904,BL0398905, BL0401593, BL0401594,BL0401595,BL0401596, BL0414567, BL0213751, BL0401953, BL0379361, BL0130764, BL0130785, BL0152618, BL0194187, BL0195884, BL0199981, BL0200022
Therapeutic Target DatabaseT77365
ChEMBLCHEMBL251
IUPHAR19
DrugBankBE0000924

Ligand

Name8-Cyclopentyl-1,3-dipropylxanthine
Molecular formulaC16H24N4O2
IUPAC name8-cyclopentyl-1,3-dipropyl-7H-purine-2,6-dione
Molecular weight304.394
Hydrogen bond acceptor3
Hydrogen bond donor1
XlogP4.0
SynonymsFFBDFADSZUINTG-UHFFFAOYSA-N
ZX-AT022179
HMS500I19
KBio3_001906
LS-126534
[ Show all ]
Inchi KeyFFBDFADSZUINTG-UHFFFAOYSA-N
Inchi IDInChI=1S/C16H24N4O2/c1-3-9-19-14-12(15(21)20(10-4-2)16(19)22)17-13(18-14)11-7-5-6-8-11/h11H,3-10H2,1-2H3,(H,17,18)
PubChem CID1329
ChEMBLCHEMBL183
IUPHAR386
BindingDB21173
DrugBankN/A

Structure

SDF download

2D structure
Lipinski's druglikenessThis ligand satisfies Lipinski's rule of five.

Experimental Data

ParameterValueReferenceDatabase source
ED50<10.0 uMPMID8676354ChEMBL
IC50217.0 nMPMID10476879BindingDB,ChEMBL
IC50261.0 nMPMID10476879BindingDB,ChEMBL
Kd30.0 nMPMID27282729BindingDB
Kd76.29 nMDOI: http://dx.doi.org/10.6019/CHEMBL3885741ChEMBL
Kd106.44 nMDOI: http://dx.doi.org/10.6019/CHEMBL3885741ChEMBL
Ki56.0 nMPMID16250647BindingDB,ChEMBL
Ki63.0957 - 251.189 nMPMID9459566, PMID9933143, PMID9920286, PMID9179373, PMID16902942IUPHAR
Ki70.0 nMPMID10476879BindingDB,ChEMBL
Ki129.0 nMPMID18258439, J Med Chem. 2005 Mar 24;48(6):2045-53., PMID23200243, PMID15771447, PMID9459566PDSP,BindingDB,ChEMBL
Ki130.0 nMPMID20408530, PMID18637670, PMID19036477, PMID19282184BindingDB,ChEMBL
Ki144.0 nMPMID15163184BindingDB,ChEMBL
Ki156.0 nMPMID11809867PDSP,BindingDB
Ki157.0 nMPMID26824742BindingDB,ChEMBL
Ki200.0 nMPMID15163184BindingDB,ChEMBL
Ki226.0 nMPMID9258366BindingDB,ChEMBL
Ki260.0 nMPMID19301821, PMID20937560, PMID17665891, PMID25462223, PMID16789747, PMID18468446, PMID16335918BindingDB,ChEMBL
Ki260.3 nMPMID25462223ChEMBL
Ki291.0 nMPMID9258366BindingDB,ChEMBL
Ki330.0 nMPMID2825043BindingDB
Ki337.0 nMPMID17927167, PMID15214785, PMID16789747, PMID24077183, PMID18269230, PMID22257095, PMID11462973, PMID16366607, PMID10956220, PMID27282729, PMID16335918BindingDB,ChEMBL
Ki337.0 nMPMID10956220BindingDB
Ki340.0 nMPMID8071944BindingDB,ChEMBL
Ki630.0 nMPMID23200243ChEMBL
Ki788.0 nMPMID9258366BindingDB,ChEMBL
koff0.4596 min^-1DOI: http://dx.doi.org/10.6019/CHEMBL3885741ChEMBL
kon0.00306 nM^-1 min^-1DOI: http://dx.doi.org/10.6019/CHEMBL3885741ChEMBL
kon451467.0 Ms-1DOI: http://dx.doi.org/10.6019/CHEMBL3885741ChEMBL
kon482900.0 Ms-1DOI: http://dx.doi.org/10.6019/CHEMBL3885741ChEMBL
k_off0.03484 s-1DOI: http://dx.doi.org/10.6019/CHEMBL3885741ChEMBL
k_off0.04447 s-1DOI: http://dx.doi.org/10.6019/CHEMBL3885741ChEMBL

zhanglabzhanggroup.org | (734) 647-1549 | 100 Washtenaw Avenue, Ann Arbor, MI 48109-2218